Related Experiment Video
Updated: Sep 9, 2025

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
Published on: January 12, 2018
Exploring barriers, needs, and facilitators for clinical and translational research in Oklahoma: A sequential
Motolani E Ogunsanya1,2, Laura A Beebe3, Janis E Campbell3
1Department of Family and Preventive Medicine, University of Oklahoma Health Sciences, Oklahoma City, OK, USA.
Clinical and translational research (CTR) in Oklahoma faces barriers like limited funding and protected time. Enhancing mentorship and decentralized support is crucial for improving health outcomes.
Area of Science:
- Health Services Research
- Translational Medicine
- Health Equity
Background:
- Clinical and translational research (CTR) is essential for improving health outcomes.
- Success in CTR depends on institutional support, infrastructure, and workforce capacity.
- Understanding specific challenges in diverse regions is vital for targeted improvements.
Purpose of the Study:
- To explore barriers, needs, and facilitators for conducting CTR in Oklahoma.
- To identify strengths and gaps within Oklahoma's research ecosystem.
- To inform strategies for strengthening CTR capacity in underserved regions.
Main Methods:
- A sequential, descriptive mixed-methods design was used.
- Survey data (n=164) assessed infrastructure, funding, and workforce needs.
- Qualitative focus groups (n=23) explored researchers' experiences and institutional challenges.
Main Results:
- Key barriers include lack of protected research time (23.9%) and limited pilot funding (15.3%).
- Researchers need centralized tools for networking, writing, and data access.
- Facilitators include professional development and mentoring, but reliance on a single source (OSCTR) was noted.
Conclusions:
- Oklahoma's CTR infrastructure has expanded but requires improvements in mentorship, data access, and institutional support.
- Investing in decentralized systems, bridge funding, and structured mentorship is recommended.
- Findings can inform policy for strengthening CTR in Oklahoma and similar regions.
Related Concept Videos
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Preclinical Development: Overview
Study Designs in Epidemiology
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
Longitudinal Research

